Dihydropyrimidine Dehydrogenase (DPYD) Genotyping
Ferritin
Cancer Antigen (CA) 19-9, Serum
Partner and Localizer of BRCA2 (PALB2) Gene Mutation Analysis
Avantect Pancreatic Cancer Test
MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
Colon Cancer Multi-Gene Panel, NGS (ColoNext®, COLONSEQ, COLONSEQPlus)
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
Oncology Pharmacogenetics (PGx) Gene Variation Panel
MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
Medical Test
Methodology
Access to
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
is restricted.
Sign up now
Loading...